We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview (1)
- Eosinophil morphology
- Eosinophil granules
- Eosinophil granule morphology
- Eosinophil development (mouse) (1)
- Defective granule biogenesis prevents eosinophil development
- Eosinophil development (mouse) (2)
- Eosinophil tissue distribution at baseline
- Eosinophil recruitment into tissues
- Eosinophil priming, activation and survival
- Summary – part I
- Overview (2)
- Eosinophil secretion (1)
- Traditional view of eosinophil degranulation
- Challenges to traditional paradigm (1)
- Relative percentages of cytokines
- Human blood eosinophils storage
- Challenges to traditional paradigm (2)
- Piecemeal degranulation (1)
- Piecemeal degranulation (2)
- Eosinophil secretion (2)
- Membrane phospholipids
- Eosinophil secretion (3)
- Eosinophil-derived mediators
- Eosinophil functions in allergic diseases: Tissue damage, repair and remodeling
- Eosinophil functions in allergic diseases: Cell activation
- Eosinophil functions in allergic diseases: Immunomodulation
- Eosinophil functions in allergic diseases: Humoral immunity
- Eosinophil functions in allergic diseases: Overview
- Overview (3)
- Mechanisms of eosinophil degranulation (1)
- Mechanisms of eosinophil degranulation (2)
- Cell-free eosinophil granules
- Eosinophil granules
- Mechanisms of eosinophil degranulation (3)
- Summary - part II
- Functions of eosinophils in allergic diseases
- Thank you
Topics Covered
- Eosinophil morphology, development, and tissue distribution in health
- Mechanisms of eosinophil tissue recruitment in allergic diseases
- Eosinophil effector functions: Exocytosis and the traditional paradigm
- Eosinophil modes of degranulation revisited
- Eosinophil effector functions: Piecemeal degranulation and an evolving paradigm
- Release of eosinophil extracellular granules and DNA traps
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Spencer, L.A. (2020, March 29). Eosinophil functions in allergic diseases: an evolving paradigm [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/RDVO8023.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Lisa A. Spencer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Allergy - From Basics to Clinic
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Lisa Spencer,
and I've been asked to speak today about eosinophil functions in allergic diseases.
0:08
I've broken this talk down into two parts.
In the first part, we'll talk about an introduction to eosinophils.
This is really just an overview.
It's not a comprehensive overview,
but we'll touch upon things like the morphology and development.
We'll look at tissue distribution at baseline,
and also their recruitment into allergic diseases,
and key mediators of priming, activation, and survival.
The point here is really not to provide a comprehensive overview of these styles,
but rather to try to highlight some of those key mediators that would help give
a perspective and a rationale behind some of the emerging therapeutics.
Really the main focus of what we'll talk about today is
this idea of effector functions of eosinophils in allergic diseases.
Traditionally, this has really been more of
an effector end-stage cell, type of a thought.
This is the traditional paradigm.
But what I hope to share with you today is that this paradigm is really evolving.
Instead of just being strictly an end-stage effector cells,
these eosinophils are really involved in many more multifaceted,
nuanced aspects of allergic diseases.
In addition, we'll spend a few minutes at the end to
talk about some newer data that really talks about
the possibility that eosinophils are actually contributing to
allergic diseases even in the absence of an intact cell,
so we'll term these "postmortem contributions."
1:26
Discussing eosinophil morphology, what you'll see here
is a typical staining of an eosinophil in a blood smear.
Now this is a human eosinophil.
If this were a mouse eosinophil,
the nucleus would look more like a doughnut shape.
What you first notice is,
of course, the bi-lobed nucleus,
and also these very bright,
pink stained granule or eosin-loving granules.
These granules really pull up this eosin dye or bind to this eosin dye very readily.
When you compare these granulocytes to other granulocytes, for example,
neutrophils on the top or mast cells on the bottom image there,
you can see that the pink granules of the eosinophils are really distinct.
This eosin affinity is distinctive for the eosinophils,
and this is where they get their name, eosinophil or eosin-loving.